MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
MiMedx's profit margin for the twelve months ending Sep 30, 2026 was -6.3%. For fiscal 2025 it was 11.6%, against 12.2% the year before. The highest annual figure on record is 20.2% in fiscal 2017.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.6% | −0.6 |
| FY2024 | Dec 31, 2024 | 12.2% | −6.0 |
| FY2023 | Dec 31, 2023 | 18.1% | +29.4 |
| FY2022 | Dec 31, 2022 | -11.3% | −7.0 |
| FY2021 | Dec 31, 2021 | -4.2% | +15.6 |
| FY2020 | Dec 31, 2020 | -19.9% | −11.3 |
| FY2019 | Dec 31, 2019 | -8.5% | −0.2 |
| FY2018 | Dec 31, 2018 | -8.3% | −28.5 |
| FY2017 | Dec 31, 2017 | 20.2% | +20.0 |
| FY2016 | Dec 31, 2016 | 0.2% | −15.5 |
| FY2015 | Dec 31, 2015 | 15.7% | +10.5 |
| FY2014 | Dec 31, 2014 | 5.3% | +12.2 |
| FY2013 | Dec 31, 2013 | -6.9% | +21.4 |
| FY2012 | Dec 31, 2012 | -28.3% | +103.0 |
| FY2011 | Dec 31, 2011 | -131.4% | +1316.2 |
| FY2010 | Dec 31, 2010 | -1447.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -13.9% | −28.7 |
| Q2 FY2026 | Jun 30, 2026 | -23.1% | −32.8 |
| Q1 FY2026 | Mar 31, 2026 | -18.4% | −26.4 |
| Q4 FY2025 | Dec 31, 2025 | 12.9% | +4.9 |
| Q3 FY2025 | Sep 30, 2025 | 14.7% | +5.1 |
| Q2 FY2025 | Jun 30, 2025 | 9.8% | −10.5 |
| Q1 FY2025 | Mar 31, 2025 | 8.0% | −3.0 |
| Q4 FY2024 | Dec 31, 2024 | 8.0% | −53.6 |
| Q3 FY2024 | Sep 30, 2024 | 9.6% | −0.8 |
| Q2 FY2024 | Jun 30, 2024 | 20.2% | +18.7 |
| Q1 FY2024 | Mar 31, 2024 | 10.9% | +17.9 |
| Q4 FY2023 | Dec 31, 2023 | 61.6% | +62.1 |
| Q3 FY2023 | Sep 30, 2023 | 10.4% | +22.9 |
| Q2 FY2023 | Jun 30, 2023 | 1.5% | +17.7 |
| Q1 FY2023 | Mar 31, 2023 | -7.0% | +10.9 |
| Q4 FY2022 | Dec 31, 2022 | -0.6% | −4.9 |
| Q3 FY2022 | Sep 30, 2022 | -12.4% | −8.7 |
| Q2 FY2022 | Jun 30, 2022 | -16.2% | −13.6 |
| Q1 FY2022 | Mar 31, 2022 | -17.8% | −3.8 |
| Q4 FY2021 | Dec 31, 2021 | 4.4% | +28.5 |
| Q3 FY2021 | Sep 30, 2021 | -3.7% | +26.5 |
| Q2 FY2021 | Jun 30, 2021 | -2.6% | +13.2 |
| Q1 FY2021 | Mar 31, 2021 | -14.0% | −6.2 |
| Q4 FY2020 | Dec 31, 2020 | -24.2% | −14.4 |
| Q3 FY2020 | Sep 30, 2020 | -30.2% | −44.1 |
| Q2 FY2020 | Jun 30, 2020 | -15.8% | +9.7 |
| Q1 FY2020 | Mar 31, 2020 | -7.8% | +12.1 |
| Q4 FY2019 | Dec 31, 2019 | -9.8% | +29.3 |
| Q3 FY2019 | Sep 30, 2019 | 13.9% | +14.1 |
| Q2 FY2019 | Jun 30, 2019 | -25.5% | −27.4 |
| Q1 FY2019 | Mar 31, 2019 | -19.9% | −25.4 |
| Q4 FY2018 | Dec 31, 2018 | -39.1% | −44.0 |
| Q3 FY2018 | Sep 30, 2018 | -0.2% | −52.6 |
| Q2 FY2018 | Jun 30, 2018 | 1.9% | −11.0 |
| Q1 FY2018 | Mar 31, 2018 | 5.5% | −3.2 |
| Q4 FY2017 | Dec 31, 2017 | 4.9% | −3.0 |
| Q3 FY2017 | Sep 30, 2017 | 52.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 12.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 8.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 7.8% | – |
See a number that looks wrong?